Safi Biotherapeutics, a biotech company producing stem-cell derived, manufactured human red blood cell (mRBC) products for civilian and military transfusion needs, and ARMI | BioFabUSA , a non-profit organization and Department of Defense Manufacturing Innovation Institute, today announced a collaboration focused on the manufacturing of Safi’s...
A major investment is coming to New Hampshire to get a cutting-edge industry off the ground.
U.S. Commerce Secretary Gina Raimondo visited BioFabUSA in Manchester on Friday to discuss the grant, which will help the program develop human tissue that's suitable for transplants.
"What's happening here at BioFab is incredible," Raimondo said. "It's...
Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that CEO Jeff Ross will be a keynote speaker at BioFabUSA’s 2022 Fall Summit from the Advanced Regenerative Manufacturing Institute (ARMI).
Mr. Ross...
Dr. Doris Taylor, CEO Organamet Bio Inc., is developing a groundbreaking way to engineer personalized hearts using a patient's own stem cells. She is a member of the Leadership Advisory Council of BioFabUSA, a 91¿´Æ¬ institute.
President Biden unveiled a plan to expand biomanufacturing, and biotechnology with $2 billion pledged for a variety of efforts last week. Some of these initiatives may have special appeal to North Carolina’s growing life science sector.
Nearly 800 life sciences companies employ some 70,000 people in the state, according to the ...
